Evidence map›Paper›PMID 30104465›Full record

ArticleInternational journal of molecular sciences2018

The ATR-Activation Domain of TopBP1 Is Required for the Suppression of Origin Firing during the S Phase.

Miiko Sokka, Dennis Koalick, Peter Hemmerich, Juhani E Syväoja, Helmut Pospiech

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Special Issue on DNA Replication Stress: Summary of Topics Covered.International journal of molecular sciences · 2019
    Article
  12. The Protective Role of Dormant Origins in Response to Replicative Stress.International journal of molecular sciences · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miiko SokkaDepartment of Biology, University of Eastern Finland, FI-80101 Joensuu, Finland. miiko_sokka@brown.edu.ORCID 0000-0002-3091-3754
Dennis KoalickLeibniz Institute on Aging-Fritz Lipmann Institute, DE-07745 Jena, Germany. dennis.koalick@yahoo.com.
Peter HemmerichLeibniz Institute on Aging-Fritz Lipmann Institute, DE-07745 Jena, Germany. peter.hemmerich@leibniz-fli.de.
Juhani E SyväojaInstitute of Biomedicine, University of Eastern Finland, FI-70211 Kuopio, Finland. juhani.syvaoja@live.com.
Helmut PospiechLeibniz Institute on Aging-Fritz Lipmann Institute, DE-07745 Jena, Germany. helmut.pospiech@leibniz-fli.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian DNA replication program is controlled at two phases, the licensing of potential origins of DNA replication in early gap 1 (G1), and the selective firing of a subset of licenced origins in the synthesis (S) phase. Upon entry into the S phase, serine/threonine-protein kinase ATR (ATR) is required for successful completion of the DNA replication program by limiting unnecessary dormant origin activation. Equally important is its activator, DNA topoisomerase 2-binding protein 1 (TopBP1), which is also required for the initiation of DNA replication after a rise in S-phase kinase levels. However, it is unknown how the ATR activation domain of TopBP1 affects DNA replication dynamics. Using human cells conditionally expressing a TopBP1 mutant deficient for ATR activation, we show that functional TopBP1 is required in suppressing local dormant origin activation. Our results demonstrate a regulatory role for TopBP1 in the local balancing of replication fork firing within the S phase.

Indexed as

Carrier ProteinsCell Line, TumorDNA-Binding ProteinsDNA, Single-StrandedDoxycyclineHumansMicroscopy, FluorescenceMutagenesis, Site-DirectedNuclear ProteinsProtein DomainsS PhaseTranscription, GeneticCarrier ProteinsDNA-Binding ProteinsDNA, Single-StrandedDoxycyclineNuclear ProteinsTOPBP1 protein, humanATRDNA fiber assayDNA replicationorigin firingS phaseTopBP1

Identifiers

PMID30104465
PMCPMC6121618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.